Monodispersed DOTA-PEG-conjugated anti-TAG-72 diabody has low kidney uptake and high tumor-to-blood ratios resulting in improved 64Cu PET.
Monodispersed DOTA-PEG-conjugated anti-TAG-72 diabody has low kidney uptake and high tumor-to-blood ratios resulting in improved 64Cu PET.
复制标题
DOI:
10.2967/jnumed.109.074153
复制
发表时间:
2010-07
期刊:
影响因子:
--
通讯作者:
Shively JE
中科院分区:
文献类型:
--
作者:
Li L;Turatti F;Crow D;Bading JR;Anderson AL;Poku E;Yazaki PJ;Williams LE;Tamvakis D;Sanders P;Leong D;Raubitschek A;Hudson PJ;Colcher D;Shively JE
Diabodies are non-covalent dimers of single chain antibody fragments (scFvs) that retain the avidity of intact IgG but have more favorable blood clearance than intact IgGs. Radiometals offer a wide range of half lives and emissions for matching imaging and therapy requirements and provide facile labeling of chelate-antibody conjugates. However, due to their high retention and metabolism in the kidney, use of radiometal labeled diabodies can be problematic for both imaging and therapy. Having previously shown that 111In-DOTA-PEG3400-anti-CEA-diabody has similarly high tumor uptake and retention and less than 50% as much kidney uptake and retention as non-PEGylated diabody, we synthesized a similar derivative for an anti-TAG-72-diabody. We also reduced the molecular size of the polydispersed PEG3400 to monodispersed PEG27 and PEG12 (nominal masses of 1188 and 528, respectively). We performed biodistributions of their DOTA conjugates radiolabeled with 125I, 111In, or 64Cu in tumor bearing athymic mice. Addition of PEG3400 to the diabody reduced kidney uptake to a level (≈10 %ID/g) comparable to that obtained with radiometal labeled intact IgG. The PEG27 and PEG12 diabody conjugates also demonstrated low kidney uptake without reduction of tumor uptake or tumor to blood ratios. When radiolabeled with 64Cu, the DOTA-PEG12- and PEG27-diabody conjugates gave high contrast PET images of colon cancer xenografts in athymic mice. PEGylated diabodies may be a valuable platform for delivery of radionuclides and other agents to tumors.
登录
查看更多内容
DOI:
10.1007/s00259-004-1664-0
发表时间:
2005-03-01
影响因子:
9.1
作者:
Chauhan, SC;Jain, M;Batra, SK
通讯作者:
Batra, SK
影响因子:
4.7
作者:
Tsai, SW;Li, L;Shively, JE
通讯作者:
Shively, JE
影响因子:
3.9
作者:
Gangopadhyay, A;Thomas, P
通讯作者:
Thomas, P
影响因子:
11.2
作者:
Olafsen, T;Kenanova, VE;Wu, AM
通讯作者:
Wu, AM
影响因子:
4.7
作者:
Li, L;Tsai, SW;Shively, JE
通讯作者:
Shively, JE